Melanoma in Grey Horses | Animal Welfare Hub

Grey horses face a near-universal risk of developing melanomas — tumours that affect quality of life and pose unique management challenges as horses age.

Key Facts

Up to 80% of grey horses over 15 years old develop melanoma tumours, making it one of the most common equine cancers by far
Grey horse melanomas arise from abnormal melanocyte activity linked to the greying gene (STX17), which causes progressive depigmentation
Tumours most commonly appear under the tail, around the perineum, and at the lips and eyes — sites that can cause functional problems
Unlike in humans, most equine melanomas are slow-growing and initially benign, but a significant proportion eventually become malignant
Malignant transformation causes internal spread (to lymph nodes, lungs, and gut) and is associated with significant pain and decline
Treatments include surgical excision, cimetidine (with variable evidence), immunotherapy (cisplatin implants), and emerging vaccine approaches
Genetic research has identified the mechanism of grey-associated melanoma, opening pathways for targeted prevention and treatment

Welfare Considerations

Melanoma in grey horses presents a complex welfare challenge — most horses live comfortably with tumours for years, but monitoring is essential to detect malignant change before suffering becomes severe. Perianal and perineal tumours can interfere with defecation, urination, and reproduction, causing chronic discomfort even when not malignant. Owner awareness of tumour location and size is critical, as rapid growth or behavioural changes signal the need for prompt veterinary assessment. Proactive pain management, appropriate surgical referral, and frank end-of-life planning are all important elements of welfare-conscious care for affected horses.

What You Can Do

Examine grey horses regularly (monthly) for new or rapidly growing tumour masses, particularly under the tail and around the perineum
Establish a baseline record of tumour number, size, and location to detect changes early
Consult an equine vet or oncologist promptly if tumours grow rapidly, ulcerate, or cause behavioural changes
Discuss emerging immunotherapy and vaccine trials with your vet — clinical research is actively advancing in this area
Plan for end-of-life considerations honestly — quality of life must guide decisions when internal spread occurs
Support equine cancer research through donations to veterinary schools conducting melanoma studies
Breed registries and welfare organisations should include grey horse melanoma in owner education programmes